DOPR
2,5-dimethoxy-4-propylamphetamine
1Provenance card
the boundary, as counts
Sources
2213 with DOI
4 strong · 12 moderate · 6 weak
Compilations
12026-05-09T05:12:45.434Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
30last ruled 2026-06-04
0 awaiting a ruling
Issued documents
62026-10-19T20:31:43.044Z
notice · info card · emergency
Searches
191 with no results
queries and counts on the build
Claims checked
5036 supported
36 supported · 14 not
Correspondence
0received
consent field ships in Phase 4
Edges
187
derivations recorded for this entity
Complete over 22 sources, 1 compilation, and 30 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/dopr/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-19issueIssued notice
- 2026-09-07srcPharmacology and Toxicology of N-Benzylphenethylamine (NBOMe) Hallucinogens
- 2026-09-07srcChemistry and Structure-Activity Relationships of Psychedelics.
- 2026-09-07srcHallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
- 2026-09-07srcChronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen
- 2026-09-07srcSerotonin toxicity of serotonergic psychedelics
- 2026-09-07srcAnalysis of 2,5-dimethoxy-amphetamines and 2,5-dimethoxy-phenethylamines aiming their determination in biological matrices: a review.
- 2026-09-07srcLow (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice
- 2026-09-07src1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review.
- 2026-09-07srcMechanisms and Molecular Targets Surrounding the Potential Therapeutic Effects of Psychedelics
- 2026-09-07srcThe 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects
- 2026-09-07srcBehavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex
- 2026-09-07srcPsychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
- 2026-09-07src5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex
- 2026-09-07srcDifferential phospholipase C activation by phenylalkylamine serotonin 5-HT2A receptor agonists
- 2026-09-07srcEffect of a chiral 4-alkyl substituent in hallucinogenic amphetamines.
- 2026-09-07srcDirectional lipophilic character in a series of psychotomimetic phenethylamine derivatives
- 2026-09-07srcDOPR - NCATS Inxight Drugs Database
- 2026-09-07src2,5-Dimethoxy-4-propylamphetamine - Wikipedia
- 2026-09-07srcPiHKAL: A Chemical Love Story
- 2026-09-07srcHandWiki: Chemistry:2,5-Dimethoxy-4-propylamphetamine
- 2026-09-07srcDOPR (hydrochloride) product page
- 2026-09-07srcCritical Review Report: DOC (4-Chloro-2,5-dimethoxyamfetamine)
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-09revisionRevision 1
- 2026-05-09absenceSearched ClinicalTrials.gov for "DOPR 2,5-dimethoxy-4-propylamphetamine psychedelic" — no results
- 2026-05-09genGeneration — pipeline-v5 · with 4 morepipeline-v5
- 2026-05-09rungeneration run
The same entries, as forms: six forms.